NASDAQ:PRPO

Precipio Stock Insider Trading

Healthcare > Medical - Diagnostics & Research

Buy PRPO

*Your capital is at risk

$21.65

+0.460 (+2.17%)

At Close: Jul 31, 2026

Precipio Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -0.600. In total, the insiders bought 173.31K and sold 44.34K PRPO shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-0.600
● Buy	173.31K shares
● Sell	44.34K shares
90% Buy Activity Moderate Positive Correlation
Sell Signal Medium Confidence May 21, 2026 Analysis Breakdown: Partially supported by a positive historical correlation. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Jul 15, 2026 Buy	Common Stock A-Award	Cohen David Seth Director	Director	520 Value: $13.1K
Jul 15, 2026 Buy	Common Stock A-Award	Cossman Jeffrey Director	Director	416 Value: $10.5K
Jul 15, 2026 Buy	Common Stock A-Award	Valauri Christina Rizopoulos Director	Director	108 Value: $3K
May 21, 2026 Sell	Common Stock S-Sale	Sandberg Richard A Director	Director	900 Value: $22.5K
May 20, 2026 Sell	Common Stock S-Sale	Sandberg Richard A Director	Director	500 Value: $12.5K
May 20, 2026 Sell	Common Stock S-Sale	Sandberg Richard A Director	Director	2 034 Value: $50.6K
May 19, 2026 Sell	Common Stock S-Sale	Sandberg Richard A Director	Director	600 Value: $14.7K
Apr 15, 2026 Buy	Common Stock A-Award	Cohen David Seth Director	Director	445 Value: $13.1K
Apr 15, 2026 Buy	Common Stock A-Award	Cossman Jeffrey Director	Director	365 Value: $10.8K
Apr 15, 2026 Buy	Common Stock A-Award	Valauri Christina Rizopoulos Director	Director	93 Value: $3K
Apr 01, 2026 Buy	Common Stock P-Purchase	Sabet Ahmed Zaki Chief Operating Officer	C-Suite Officer	19 Value: $531
Jan 15, 2026 Buy	Common Stock A-Award	Cohen David Seth Director	Director	546 Value: $13.1K
Jan 15, 2026 Buy	Common Stock A-Award	Cossman Jeffrey Director	Director	437 Value: $10.5K
Jan 15, 2026 Buy	Common Stock A-Award	Laporte Kathleen Director	Director	520 Value: $12.5K
Jan 15, 2026 Buy	Common Stock A-Award	Valauri Christina Rizopoulos Director	Director	406 Value: $10K
Jan 02, 2026 Buy	Common Stock P-Purchase	Sabet Ahmed Zaki Chief Operating Officer	C-Suite Officer	20 Value: $468
Jan 02, 2026 Buy	Stock Option (Right to Buy) A-Award	Valauri Christina Rizopoulos Director	Director	1 500 Value: $35.7K
Jan 02, 2026 Buy	Stock Option (Right to Buy) A-Award	Sabet Ahmed Zaki Chief Operating Officer	C-Suite Officer	15 000 Value: $357.3K
Jan 02, 2026 Buy	Common Stock P-Purchase	Sabet Ahmed Zaki Chief Operating Officer	C-Suite Officer	20 Value: $468
Jan 02, 2026 Buy	Stock Option (Right to Buy) A-Award	Sandberg Richard A Director	Director	1 500 Value: $35.7K
Jan 02, 2026 Buy	Stock Option (Right to Buy) A-Award	Gage Matthew Chief Financial Officer	C-Suite Officer	5 000 Value: $119.1K
Jan 02, 2026 Buy	Stock Option (Right to Buy) A-Award	Cossman Jeffrey Director	Director	1 500 Value: $35.7K
Jan 02, 2026 Buy	Stock Option (Right to Buy) A-Award	Andrews Ronald Asbury Director	Director	1 500 Value: $35.7K
Jan 02, 2026 Buy	Stock Option (Right to Buy) A-Award	Cohen David Seth Director	Director	1 500 Value: $35.7K
Jan 02, 2026 Buy	Stock Option (Right to Buy) A-Award	Danieli Ilan Chief Executive Officer	CEO / President	15 000 Value: $357.3K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT PRECIPIO, INC.

Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; ICE-COLD PCR, a proprietary and patented specimen technology that increases the se...

Read Full Profile Here